Morphle Labs raises $5M in Series A round from Inflexor Ventures

Morphle Labs, a healthcare automation company specializing in robotic and imaging systems for cancer diagnostics, has raised $5 million in a Series A funding round led by Inflexor Ventures.

The funding will help Morphle Labs to expand globally, scale production of its flagship products RoboTome and MorphoLens, secure international regulatory approvals, and strengthen its technology and IP as it enters major markets.

Read also- Mobavenue AI Tech To Raise INR 100 Cr To Boost AI Growth

“Our vision at Morphle is to rethink healthcare from the ground up. Histology remains one of the few critical domains still untouched by true automation, and that is where we have chosen to start. With RoboTome and MorphoLens, we have tackled two of the most challenging bottlenecks in diagnostics, high-throughput robotic microtomy and robust, modular slide imaging, but this is only the beginning. The larger opportunity lies in stitching together every broken link in the diagnostics chain, enabling labs to deliver faster, higher-quality results and empowering pathologists to focus on what matters most: the diagnosis," Rohit Hiwale, Founder & CEO, Morphle Labs, said.

"With this funding we will also be expanding our team, While solving some extremely valuable problems for mankind, we are on a mission to improve talent density across Robotics & computer vision," he added.

“Morphle Labs is transforming one of the most overlooked yet mission-critical segments of global healthcare. Their ability to bring together robotics, imaging and AI into clinically reliable systems is exceptional. The traction they are already seeing with leading labs in the U.S. and Europe demonstrates both the scale of the problem and Morphle’s ability to solve it. We believe they are poised to become a global leader in tissue diagnostics automation, and we are excited to support their journey,” added Pratip Mazumdar, Partner at Inflexor Ventures.

About Morphle Labs

Founded in 2017 by Rohit Hiwale and Anchit Navelkar, Morphle Labs uses robotics, precision hardware, optics, and AI to develop advanced tools for automating tissue diagnostics.

The company has filed over 80 patents in robotics, optics, embedded systems, and imaging, and is expanding its presence in the US and Europe.

Advertisment

Its flagship product, RoboTome, automates slicing tissue blocks into thin sections for microscope slides, helping pathologists get cleaner slides for faster and more accurate cancer diagnosis.

MorphoLens is a digital slide scanner that allows doctors and technicians to examine tissues in detail and detect tiny cellular abnormalities.

HemoLabs is designed to locate blood cells and platelet fragments for sorting and testing. Morphle Labs is part of a growing wave of healthcare deeptech startups raising early funding to accelerate R&D and commercial rollout.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Latest Business and Startup News: Discover Funding Trends and Stories Shaping Indian Startups.

Startup Funding News: Your Gateway to Every Funding Update.

Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Advertisment

Startup Stories: Discover inspiring tales of startups overcoming challenges, and achieving success.